Journey Medical Corporation - stock earnings
DERM Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 27, 2024 BeforeMarket | - / -0.2600000000 | - | - / 14.1 million | - |
DERM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 16.8 million USD | 34.5 million USD |
| 2023Q2 | -8.4 million USD | 17.2 million USD |
| 2023Q1 | -10.1 million USD | 12.2 million USD |
| 2022Q4 | -10.6 million USD | 16.0 million USD |
| 2022Q3 | -10.1 million USD | 16.1 million USD |
| 2022Q2 | -7.5 million USD | 18.3 million USD |
| 2022Q1 | -1.4 million USD | 23.3 million USD |
| 2021Q4 | -21.8 million USD | 17.5 million USD |
| 2021Q3 | -10.6 million USD | 19.6 million USD |
| 2021Q2 | -11.9 million USD | 15.3 million USD |
| 2021Q1 | 268000 USD | 10.7 million USD |
| 2020Q4 | 2.5 million USD | 13.7 million USD |
| 2020Q3 | 29000 USD | 9.4 million USD |
| 2020Q2 | 455000 USD | 9.4 million USD |
| 2019Q3 | -57.6 million USD | 11.5 million USD |
| 2019Q2 | -18.0 million USD | 66.6 million USD |
| 2019Q1 | -64.8 million USD | 2.5 million USD |
| 2018Q4 | -71.8 million USD | 2.2 million USD |
| 2018Q3 | -66.5 million USD | 717000 USD |
| 2018Q2 | -23.9 million USD | 39.1 million USD |
| 2018Q1 | -59.3 million USD | 299000 USD |
| 2017Q4 | -56.0 million USD | 1.3 million USD |
| 2017Q3 | -179.2 million USD | 1.1 million USD |
| 2017Q2 | -38.6 million USD | 1.1 million USD |
| 2017Q1 | -29.5 million USD | 1.1 million USD |
| 2016Q4 | -7.4 million USD | 22.5 million USD |
| 2016Q3 | -25.5 million USD | 119000 USD |
| 2016Q2 | -56.2 million USD | ? USD |
| 2016Q1 | -28.4 million USD | ? USD |
| 2015Q4 | -78.4 million USD | 7.3 million USD |
| 2015Q3 | -16.1 million USD | 7.3 million USD |
| 2015Q2 | -31.2 million USD | ? USD |
| 2015Q1 | -14.0 million USD | ? USD |
| 2014Q4 | -6.7 million USD | 7.3 million USD |
DERM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -12.4 million USD | 79.9 million USD |
| 2022 | -29.6 million USD | 73.7 million USD |
| 2021 | -44.0 million USD | 63.1 million USD |
| 2020 | 5.3 million USD | 44.5 million USD |
| 2019 | 3.6 million USD | 34.9 million USD |
| 2018 | -221.5 million USD | 42.3 million USD |
| 2017 | -303.3 million USD | 4.5 million USD |
| 2016 | -89.1 million USD | 22.6 million USD |
| 2015 | -78.4 million USD | 7.3 million USD |
| 2014 | -31.9 million USD | 7.3 million USD |
DERM
Price: $3.69
52 week price:
Earnings Per Share: -0.69 USD
P/E Ratio: -6.99
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 25200
Ebitda: -176.2 millionMarket Capitalization: 83.3 million